These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 8073042

  • 1. Expression and characterization of apolipoprotein(a) kringle IV types 1, 2 and 10 in mammalian cells.
    Sangrar W, Marcovina SM, Koschinsky ML.
    Protein Eng; 1994 May; 7(5):723-31. PubMed ID: 8073042
    [Abstract] [Full Text] [Related]

  • 2. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
    Ernst A, Helmhold M, Brunner C, Pethö-Schramm A, Armstrong VW, Müller HJ.
    J Biol Chem; 1995 Mar 17; 270(11):6227-34. PubMed ID: 7890760
    [Abstract] [Full Text] [Related]

  • 3. Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.
    Klezovitch O, Scanu AM.
    Arterioscler Thromb Vasc Biol; 1996 Mar 17; 16(3):392-8. PubMed ID: 8630665
    [Abstract] [Full Text] [Related]

  • 4. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100.
    Rahman M, Jia Z, Gabel BR, Marcovina SM, Koschinsky ML.
    Protein Eng; 1998 Dec 17; 11(12):1249-56. PubMed ID: 9930675
    [Abstract] [Full Text] [Related]

  • 5. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein.
    Frank S, Krasznai K, Durovic S, Lobentanz EM, Dieplinger H, Wagner E, Zatloukal K, Cotten M, Utermann G, Kostner GM.
    Biochemistry; 1994 Oct 11; 33(40):12329-39. PubMed ID: 7918455
    [Abstract] [Full Text] [Related]

  • 6. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
    Rahman MN, Petrounevitch V, Jia Z, Koschinsky ML.
    Protein Eng; 2001 Jun 11; 14(6):427-38. PubMed ID: 11477223
    [Abstract] [Full Text] [Related]

  • 7. Analysis of structure--function relationships in human apolipoprotein(a).
    van der Hoek YY, Kastelein JJ, Koschinsky ML.
    Can J Physiol Pharmacol; 1994 Mar 11; 72(3):304-10. PubMed ID: 8069777
    [Abstract] [Full Text] [Related]

  • 8. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells.
    Brunner C, Lobentanz EM, Pethö-Schramm A, Ernst A, Kang C, Dieplinger H, Müller HJ, Utermann G.
    J Biol Chem; 1996 Dec 13; 271(50):32403-10. PubMed ID: 8943305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation.
    Gabel BR, May LF, Marcovina SM, Koschinsky ML.
    Arterioscler Thromb Vasc Biol; 1996 Dec 13; 16(12):1559-67. PubMed ID: 8977462
    [Abstract] [Full Text] [Related]

  • 11. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH, Lee HJ, Lee EK, Yu HK, Lee TH, Yoon Y, Kim SJ, Kim JS.
    Biol Chem; 2011 Apr 13; 392(4):347-56. PubMed ID: 21194375
    [Abstract] [Full Text] [Related]

  • 12. The Kringle V-protease domain is a fibrinogen binding region within Apo(a).
    Xue S, Madison EL, Miles LA.
    Thromb Haemost; 2001 Nov 13; 86(5):1229-37. PubMed ID: 11816712
    [Abstract] [Full Text] [Related]

  • 13. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
    Belczewski AR, Ho J, Taylor FB, Boffa MB, Jia Z, Koschinsky ML.
    Biochemistry; 2005 Jan 18; 44(2):555-64. PubMed ID: 15641780
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
    Anglés-Cano E, Rojas G.
    Biol Chem; 2002 Jan 18; 383(1):93-9. PubMed ID: 11928826
    [Abstract] [Full Text] [Related]

  • 15. The functional and clinical significance of the Met-->Thr substitution in Kringle IV type 10 of apolipoprotein(a).
    Prins J, van der Hoek YY, Biesheuvel TH, Leus FR, van Rijn HJ, Kastelein JJ.
    Thromb Res; 1998 May 01; 90(3):125-30. PubMed ID: 9684731
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation system.
    Liu L, Boffa MB, Koschinsky ML.
    PLoS One; 2013 May 01; 8(1):e52287. PubMed ID: 23326327
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W, Koschinsky ML.
    Biochem Cell Biol; 2000 May 01; 78(4):519-25. PubMed ID: 11012092
    [Abstract] [Full Text] [Related]

  • 18. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
    Koschinsky ML, Côté GP, Gabel B, van der Hoek YY.
    J Biol Chem; 1993 Sep 15; 268(26):19819-25. PubMed ID: 8366120
    [Abstract] [Full Text] [Related]

  • 19. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
    Chitayat S, Kanelis V, Koschinsky ML, Smith SP.
    Biochemistry; 2007 Feb 20; 46(7):1732-42. PubMed ID: 17263558
    [Abstract] [Full Text] [Related]

  • 20. Cloning, expression, and characterization of human apolipoprotein(a) kringle IV37.
    LoGrasso PV, Cornell-Kennon S, Boettcher BR.
    J Biol Chem; 1994 Aug 26; 269(34):21820-7. PubMed ID: 8063825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.